Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440850
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-04-19
Brief Title:
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Thyroid Gland Follicular Carcinoma |
| Thyroid Gland Oncocytic Carcinoma |
| Thyroid Gland Papillary Carcinoma |
Keywords: